Detailed description page of B3Pdb
This page provides detail information of Selected ID b3pdb_1181 |
Primary information | |
---|---|
B3PDB ID | b3pdb_1181 |
Peptide Name | RD2D3 |
PEPTIDE SEQUENCE (1-letter) | PTLHTHNRRRRRRPRTRLHTHRNR |
PEPTIDE SEQUENCE (3-letter) | Pro-Thr-Leu-His-Thr-His-Asn-Arg-Arg-Arg-Arg-Arg-Arg-Pro-Arg-Thr-Arg-Leu-His-Thr-His-Arg-Asn-Arg |
N-terminal modification | NA |
C-terminal modification | NA |
Chemical modification | NA |
Peptide Length | 24 |
Conformation | Linear |
Peptide Nature | NA |
Source/Origin of peptide | Chemically synthesized |
SMILES | NA |
Cell Line | NA |
In vitro CONCENTRATION | NA |
In vitro METHOD | NA |
In vitro RESULT | NA |
ANIMAL MODEL | NA |
In vivo CONCENTRATION | NA |
In vivo MODE OF DELIVERY | Intravenous |
In vivo METHOD | NA |
In vivo RESULT | NA |
ACTION | NA |
TRANSPORT TYPE | Permeability |
SUBCELLULAR LOCALISATION | NA |
COMBINATION | NA |
PHYSICAL CONDITION | NA |
RESPONSE | Unidirectional influx rate constant |
RESULT | 0.0003 ml/(g x min) |
LABEL | H3/C14 |
PMID | 27086111 |